D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Pfizer
PFE
|
+$439M |
| 2 |
AbbVie
ABBV
|
+$401M |
| 3 |
Johnson & Johnson
JNJ
|
+$308M |
| 4 |
Gilead Sciences
GILD
|
+$261M |
| 5 |
Mercado Libre
MELI
|
+$259M |
Top Sells
| 1 |
Booking.com
BKNG
|
+$391M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$390M |
| 3 |
Citigroup
C
|
+$315M |
| 4 |
PayPal
PYPL
|
+$282M |
| 5 |
SHPG
Shire pic
SHPG
|
+$276M |
Sector Composition
| 1 | Technology | 20.75% |
| 2 | Consumer Discretionary | 16.79% |
| 3 | Healthcare | 16.62% |
| 4 | Financials | 9.01% |
| 5 | Industrials | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Accenture
ACN
$149B
| $2.12M | ﹤0.01% |
12,032
-3,964
| -25% | -$698K |
|
1502
AngloGold Ashanti
AU
$33.5B
| $2.12M | ﹤0.01% |
161,708
-769,419
| -83% | -$10.1M |
|
1503
Thermon Group Holdings
THR
$844M
| $2.11M | ﹤0.01% |
85,865
-52,677
| -38% | -$1.29M |
|
1504
McCormick & Company Non-Voting
MKC
$18.5B
| $2.1M | ﹤0.01% |
27,890
-226,902
| -89% | -$17.1M |
|
|
GCI
1505
DELISTED
Gannett Co., Inc
GCI
| $2.1M | ﹤0.01% |
198,940
-192,662
| -49% | -$2.03M |
|
1506
Harmonic Inc
HLIT
$1.13B
| $2.09M | ﹤0.01% |
385,393
+9,027
| +2% | +$48.9K |
|
|
KAMN
1507
DELISTED
Kaman Corp
KAMN
| $2.08M | ﹤0.01% |
35,605
-21,761
| -38% | -$1.27M |
|
|
RETA
1508
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $2.08M | ﹤0.01% |
24,329
+5,133
| +27% | +$439K |
|
1509
Collegium Pharmaceutical
COLL
$1.18B
| $2.07M | ﹤0.01% |
+137,017
| New | +$2.07M |
|
1510
Wipro
WIT
$29B
| $2.07M | ﹤0.01% |
1,041,848
-918,827
| -47% | -$1.83M |
|
1511
Agree Realty
ADC
$8.09B
| $2.06M | ﹤0.01% |
29,716
-145,123
| -83% | -$10.1M |
|
1512
Vornado Realty Trust
VNO
$8.25B
| $2.06M | ﹤0.01% |
30,575
+15,426
| +102% | +$1.04M |
|
1513
Babcock & Wilcox
BW
$281M
| $2.06M | ﹤0.01% |
500,014
-162,508
| -25% | -$668K |
|
1514
Broadridge
BR
$29.5B
| $2.05M | ﹤0.01% |
+19,796
| New | +$2.05M |
|
|
LKSD
1515
DELISTED
LSC Communications, Inc.
LKSD
| $2.05M | ﹤0.01% |
314,465
+53,326
| +20% | +$348K |
|
1516
CTS Corp
CTS
$1.23B
| $2.04M | ﹤0.01% |
69,427
+30,363
| +78% | +$892K |
|
1517
Ligand Pharmaceuticals
LGND
$3.23B
| $2.04M | ﹤0.01% |
25,977
-244,875
| -90% | -$19.2M |
|
1518
KB Home
KBH
$4.48B
| $2.03M | ﹤0.01% |
84,153
-59,212
| -41% | -$1.43M |
|
1519
Camping World
CWH
$1.04B
| $2.02M | ﹤0.01% |
+145,145
| New | +$2.02M |
|
1520
Simpson Manufacturing
SSD
$7.86B
| $2.01M | ﹤0.01% |
33,937
+2,920
| +9% | +$173K |
|
|
BHVN
1521
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $2.01M | ﹤0.01% |
+39,037
| New | +$2.01M |
|
|
EPZM
1522
DELISTED
Epizyme, Inc
EPZM
| $2M | ﹤0.01% |
+161,611
| New | +$2M |
|
|
CETV
1523
DELISTED
Central European Media Enterprises Ltd
CETV
| $2M | ﹤0.01% |
503,102
+151,125
| +43% | +$601K |
|
1524
ICF International
ICFI
$1.83B
| $2M | ﹤0.01% |
26,260
-26,122
| -50% | -$1.99M |
|
1525
BBVA Argentina
BBAR
$1.84B
| $2M | ﹤0.01% |
+210,073
| New | +$2M |
|